GLOBAL October 2020
 
SweeGen commercialises its next generation Bestevia® Reb I
 
As clean-label zero-calorie natural sweeteners continue to be attractive to consumers, SweeGen announced the expansion of its natural sweetener portfolio with the commercial production of Bestevia® Reb I, a next generation high-purity stevia sweetener and flavor unique to SweeGen.
Reb I expands SweeGen’s toolbox for tackling the challenges of reducing sugar and delivering sweet taste solutions to food and beverage manufacturers. This latest addition to SweeGen’s natural sweetener portfolio works well in product applications across the spectrum ranging from dairy, beverages, nutritional bars, confectionery to savory.
Sweegen's Chief of Global Flavor Application Technology, Shari Mahon said, "Reb I is yet another unique and diverse flavor that we can use in our creative building block approach to sugar reduction for creating consumer-preferred sugar-reduced food and beverage products, and delivering winning solutions to our clients."
Reb I imparts a clean taste profile and sugar-like sweetness and complements SweeGen’s application technology. It is a versatile sweetener which can be used at various levels of sugar reduction to drive unique taste profiles.
Reb I is produced by a patented bioconversion technology, starting with the stevia leaf. This process was developed by Conagen, a biotech innovator of sustainable ingredients. SweeGen’s entire proprietary portfolio of next generation, natural Bestevia stevia sweeteners are produced with Conagen’s bioconversion technology, and are classified as next generation non-GMO, high-purity, and clean tasting. The Bestevia portfolio includes Rebs B, D, E and M, and now Reb I. These Rebs translate to highly-relevant clean-label, sustainable, natural sweeteners that consumers seek.
More than 66% of consumers prefer to see natural sweeteners rather than artificial on product labels. This trend drives brands to search for solutions in the natural sweetener and plant-based spaces which now includes Bestevia Reb I.
SweeGen has already received the FDA Generally Regarded As Safe (GRAS) no objection letter, and acceptance from The Flavor and Extract Manufacturers Association (FEMA). Global regulatory approval is also underway.
“Conagen is happy to support the successful commercialisation of Reb I as the latest offering from our pipeline of non-caloric sweeteners. We are looking forward to additional unique and novel stevia sweeteners for providing greater flexibility and options to food and beverage manufacturers,” said Conagen’s VP of Innovation, Dr. Casey Lippmeier.
SweeGen provides sweet taste solutions for global food and beverage manufacturers using its next generation stevia sweeteners in its portfolio such as Bestevia® Rebs B, D, E, I and M, along with its deep knowledge of flavor modulators and texturants.
 
X

Login

Enquiry

* denotes compulsory

Complimentary Copy

This is a onetime free circulation. For future issues, you will need to subscribe to ensure you receive timely regular copies in both printed and softcopy formats.

* denotes compulsory










Subscribe to Asia food & beverages report and get 1 year (6x) issues in printed (by mail) & softcopy (by email) as well as 1 year access to our online databank with a single user id and password. To subscribe, click to subscription now.

Subscription

* denotes compulsory

I wish to subscribe to 6 issues (1 year) of Asia food & beverages report as well as gain 1-year access to its online databank which contains past years' reports, articles and extracts at only US$300.

I wish to pay by:

Payment Type *

Print

If you would like to pay by cheque, please send the order form with cheque attached made payable to 'Consumer Goods Intelligence Pte Ltd.
Consumer Goods Intelligence Pte Ltd
10 Anson Road, #10-06 International Plaza
Singapore 079903
Tel: +65 6348 8973
Fax: +65 62275402
Email: info@asiafoodbeverages.com

Subscriber to Asia food & beverages report also gains benefits in terms of further discounts by up to 20% for advertising, advertorial and research services.